Table 3 Feasibility outcomes and process indicators
| Â | n (%) |
|---|---|
I. Training component | |
 CHWs with complete training session | 12/12 (100) |
 Physicians with complete workshop | 5/5 (100) |
II. Household component | n 185 |
Counseling session provided | 181 (97.8) |
 CVD risk module | 162 (89.5) |
 Nutritional module | 129 (71.3) |
 Physical activity module | 89 (49.2) |
Household members who received the counseling session, median (IR) | 2.0 (1–2) |
Medical appointment provided | 169 (93.4) |
CVD form included in medical records after household visit | 172 (93.0) |
 Complete in CHW’s section | 168 (97.7) |
III. Clinic component | |
 a. Attendance to clinical visit | |
Participants attending at least 1 clinical visit | 152 (82.2)a |
Number of clinical visits during the study period, mean (SD) | 1.8 (0.9) |
  1 visit | 68 (44.7) |
  2 visits | 51 (33.6) |
  3 or more visits | 33 (21.7) |
 b. CVD form | |
  Included in medical records during clinical visit | 152 (100) |
  Physicians’ section completea | 143 (94.1) |
  Nurses’ section completea | 135 (88.8) |
 c. Clinical measurements registration by nurses | |
  BP | 148 (97.4) |
  Height and weight | 141 (92.7) |
  BMI calculation | 135 (88.8) |
 d. EOVs and primary care physician’s practice | |
  EOVs successfully conducted | 10/10 (100) |
  Fasting glucose requested in diabetic participants | 44/64 (68.8) |
  Glycosylated hemoglobin requested in diabetic participants | 12/64 (18.8) |
  Drug intensification in those with any glycemic parameter available | 35/44 (79.5) |
  Drug intensification in those with BP ≥140/90 mmHgb | 87/113 (77.0) |
 e. Participants satisfaction with the multi-component interventionc | 99/103 (96.0) |